Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.

[1]  J. Pignon,et al.  Efficacy of 5FU + cisplatin (FUP) compared to bolus 5FU (FU) in advanced pancreatic carcinoma (APC) , 1999 .

[2]  M. Anscher,et al.  Preoperative Chemoradiation for Patients With Locally Advanced Adenocarcinoma of the Pancreas , 1999, Annals of Surgical Oncology.

[3]  S. Lipsitz,et al.  Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Conroy,et al.  Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  J. Jeekel,et al.  Radiotherapy and 5-FU after curative resection for the cancer of the pancreas and peri-ampullary region: A phase III trial of the EORTC GITCCG , 1997 .

[6]  A. Cooperman,et al.  Combined modality therapy for stage II and stage III pancreatic carcinoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. Tournigand,et al.  Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma. , 1997, European Journal of Cancer.

[8]  J. Lotz,et al.  Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  T. Hickish,et al.  Cisplatin and protracted venous infusion 5-fluorouracil (CF)--good symptom relief with low toxicity in advanced pancreatic carcinoma. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  D. Neuberg,et al.  Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  T. Nagakawa,et al.  Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas , 1994, Cancer.

[12]  S. Houry,et al.  Results of resection for cancer of the exocrine pancreas: A study from the French Association of Surgery , 1994, The British journal of surgery.

[13]  C. Charnsangavej,et al.  Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. , 1994, American journal of surgery.

[14]  Toshiya Takeda,et al.  An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging , 1993, Cancer.

[15]  S. Cha,et al.  Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. , 1993, International journal of radiation oncology, biology, physics.

[16]  B. Cady,et al.  Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. , 1993, Archives of surgery.

[17]  J. Pignon,et al.  Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  O. Dahl,et al.  Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study. , 1993, European journal of cancer.

[19]  H. Saeger,et al.  Survival After Pancreatoduodenectomy: 118 Consecutive Resections Without an Operative Mortality , 1990, Annals of surgery.

[20]  J. Bertino,et al.  Enhancement of the antitumor effects of 5-fluorouracil by folinic acid. , 1990, Pharmacology & therapeutics.

[21]  H. Nava,et al.  Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP). , 1988, Advances in experimental medicine and biology.

[22]  Birgir Gudjonsson,et al.  Cancer of the pancreas: 50 years of surgery , 1987, Cancer.

[23]  C. Perez,et al.  Principles and Practice of Radiation Oncology , 1987 .

[24]  J. Fourtillan,et al.  Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  N. Harada,et al.  Collective review of small carcinomas of the pancreas. , 1986, Annals of surgery.

[26]  S. Ellenberg,et al.  Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. , 1985, Archives of surgery.

[27]  J. Barkin,et al.  Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group , 1981, Cancer.

[28]  H. Keen,et al.  ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS , 1975, The Lancet.

[29]  C. Moertel,et al.  Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. , 1969, Lancet.

[30]  F. Mícek.  [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.

[31]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .